Kai Ye Selected Research

Kai Ye Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 03/2003
7	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2018
6	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2020
6	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2017
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 10/2018
4	Adenocarcinoma 02/2024 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 06/2016
4	Rectal Neoplasms (Rectal Cancer) 01/2023 - 11/2022
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2024 - 04/2014
3	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 07/2019
3	Hepatitis B 03/2023 - 11/2018
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
3	Microsatellite Instability 01/2020 - 04/2014
3	Carcinogenesis 01/2020 - 02/2019
2	Hemorrhage 01/2024 - 01/2018
2	Fibrosis (Cirrhosis) 01/2023 - 07/2019
2	Infections 12/2021 - 09/2004
2	Lymphatic Metastasis 12/2019 - 01/2018
2	Body Weight (Weight, Body) 02/2019 - 02/2019
1	Tissue Adhesions 03/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024
1	Flatulence 01/2024
1	Pneumonia (Pneumonitis) 01/2024
1	Bile Reflux 11/2023
1	Extranodal Extension 10/2023
1	Confusion (Bewilderment) 01/2023
1	Diplopia (Double Vision) 01/2023
1	Abdominal Hernia (Abdominal Hernias) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Graves Ophthalmopathy 01/2023
1	Signet Ring Cell Carcinoma 12/2022
1	Chylous Ascites 09/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Cholangiocarcinoma 01/2022
1	Constipation 04/2021
1	Atrophy 02/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 03/2023 - 03/2003
6	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 09/2004
3	Transcription Factors (Transcription Factor)IBA 04/2024 - 11/2018
3	Oncogene Proteins (Oncogene Protein)IBA 03/2023 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
2	camrelizumabIBA 02/2024 - 01/2024
2	Immunoglobulin A (IgA)IBA 10/2023 - 01/2022
2	CollagenIBA 01/2023 - 07/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022 - 07/2019
2	Indicators and Reagents (Reagents)IBA 12/2019 - 04/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Liposomes (Liposome)IBA 04/2024
1	GraphiteIBA 04/2024
1	Cytotoxins (Cytolysins)IBA 04/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2024
1	HMGB1 Protein (HMG1)IBA 02/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	SolutionsIBA 01/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	apatinibIBA 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 12/2023
1	tyramine-deoxysorbitolIBA 10/2023
1	BezafibrateIBA 03/2023
1	ActomyosinIBA 03/2023
1	Phosphotransferases (Kinase)IBA 03/2023
1	Sorafenib (BAY 43-9006)FDA Link 03/2023
1	Nonmuscle Myosin Type IIAIBA 03/2023
1	SteroidsIBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	gelatin methacryloylIBA 01/2023
1	Interleukin-12 (IL 12)IBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	CationsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	VaccinesIBA 01/2022
1	CytokinesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	TubulinIBA 02/2021
1	pyrrolineIBA 01/2021

Therapy/Procedure

10	Therapeutics 02/2024 - 11/2011
6	Gastrectomy 01/2024 - 10/2018
6	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2018
4	Colectomy 12/2022 - 01/2018
4	Immunotherapy 01/2022 - 01/2020
3	Neoadjuvant Therapy 02/2024 - 11/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2023
1	Combination Drug Therapy (Combination Chemotherapy) 04/2024
1	Quantum Dots (Quantum Dot) 04/2024
1	Transplantation 03/2024
1	Ligation 02/2024
1	Length of Stay 01/2024
1	Gastroenterostomy 11/2023
1	Pelvic Exenteration 11/2022
1	Chemoradiotherapy 04/2021